CD84 and cancer: TMEM144, enriched in monocytes and dendritic cells, is linked to M2 macrophage-driven tumour progression [88], and CD84 serves as a surface marker for myeloid-derived suppressor cells (MDSCs) [89], facilitating their detection in cancer tissues.